These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 326688)

  • 1. On the interaction between the anti-inflammatory substance proquazone (RU 43-715) and phenprocoumone.
    Vinazzer H
    Int J Clin Pharmacol Biopharm; 1977 May; 15(5):214-6. PubMed ID: 326688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Controlled, double blind study of a possible interaction between acemetacin and a concomitant anticoagulant therapy].
    Hess H; Koeppen R
    Arzneimittelforschung; 1980; 30(8A):1421-3. PubMed ID: 7191309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Course control of platelet function and blood lipid levels during a 2 years prospective study on the prevention of reinfarction with acetylsalicylic acid, phenprocoumon and placebo].
    Walter E; Weber E; Loew D
    Verh Dtsch Ges Inn Med; 1978; (84):1481-5. PubMed ID: 369187
    [No Abstract]   [Full Text] [Related]  

  • 4. Pentoxifylline does not interfere with stable coumarin anticoagulant therapy: a clinical study.
    Ingerslev J; Mouritzen C; Stenbjerg S
    Pharmatherapeutica; 1986; 4(9):595-600. PubMed ID: 3763653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new anti-inflammatory drug, proquazone, and ibuprofen in the treatment of degenerative joint disease of the knee (gonarthrosis). A double-blind comparative study.
    Puranen J; Rönty H
    Scand J Rheumatol Suppl; 1978; (21):21-4. PubMed ID: 356237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of daily administration of naproxen on the prothrombin complex activity in patients under long-term therapy with phenprocoumon.
    Petersen PB; Husted S; Mortensen A; Andreasen F
    Scand J Rheumatol; 1979; 8(1):54-6. PubMed ID: 311940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of BM 15075 on the blood coagulation system and on interaction with oral anticoagulants].
    Hoffrichter A; Zimmermann R; Walter E; Ehlers W; Andrassy K; Lang PD; Schlierf G; Weber E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1584-6. PubMed ID: 347788
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.
    Breddin K; Loew D; Lechner K; Uberla K; Walter E
    Thromb Haemost; 1979 Feb; 41(1):225-36. PubMed ID: 483232
    [No Abstract]   [Full Text] [Related]  

  • 9. [A study on interactions between pirprofen and phenprocoumon].
    Marbet GA; Duckert F; Schönenberger PM
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):207-9. PubMed ID: 3872834
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of serum triglycerides, cholesterol, uric acid and sugar levels and of thrombocyte function in heart infarct patients during a 2-year therapy with acetylsalicylic acid, placebo or phenprocoumon].
    Weber E; Walter E; Pfleiderer T
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1731-5. PubMed ID: 347797
    [No Abstract]   [Full Text] [Related]  

  • 11. Proquazone ('Biarison') in osteoarthritis of the knee: a double-blind, dose comparison trial.
    Serry MM
    Pharmatherapeutica; 1980; 2(5):323-9. PubMed ID: 7001491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
    Breddin K; Loew D; Lechner K; Oberla K; Walter E
    Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of naproxen on the thrombocyte bleeding time and on the anticoagulant treatment with phenprocoumon].
    Angelkort B
    Fortschr Med; 1978 Jun; 96(23):1249-52. PubMed ID: 658877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of sequelae after myocardial infarct. Results, methods and problems of a prospective multi-center study of the effect of acetylsalicylic acid, phenprocoumon and placebo].
    Breddin HK; Uberla KK
    Verh Dtsch Ges Inn Med; 1980; 86():1338-48. PubMed ID: 7013326
    [No Abstract]   [Full Text] [Related]  

  • 15. The concomitant use of suloctidil and a long-acting oral anticoagulant.
    Verhaeghe R; Vanhoof A
    Acta Clin Belg; 1977; 32(1):36-8. PubMed ID: 331824
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of the beta-receptor blocking agent Visken on the action of coumarin.
    Vinazzer H
    Int J Clin Pharmacol Biopharm; 1975 Dec; 12(4):458-60. PubMed ID: 1351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical study of possible interactions between indoprofen and oral anticoagulants.
    Jacono A; Caso P; Gualtieri S; Raucci D; Bianchi A; Vigorito C; Bergamini N; Iadevaia V
    Eur J Rheumatol Inflamm; 1981; 4(1):32-5. PubMed ID: 7042359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacology. Is there such a thing as a relevant drug interaction between oxazepam and phenprocoumon?].
    Schneider J; Kamm G
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1577-9. PubMed ID: 347785
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenprocoumon requirement, whole blood coagulation time, bleeding time and plasma gamma-GT in patients receiving mianserin.
    Kopera H; Schenk H; Stulemeijer S
    Eur J Clin Pharmacol; 1978 Jul; 13(5):351-6. PubMed ID: 27373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of allopurinol with phenprocoumon in man.
    Jähnchen E; Meinertz I; Gilfrich HJ
    Klin Wochenschr; 1977 Aug; 55(15):759-61. PubMed ID: 895010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.